Superimposing Status Epilepticus on Neuron Subset-Specific PTEN Haploinsufficient and Wild Type Mice Results in Long-term Changes in Behavior

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Smith, Gregory D ^a   White, Jessika ^a   Lugo, Joaquin N ^a  

^a BAYLOR UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KAINIC ACID; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PTEN PROTEIN, MOUSE;

ANIMAL; ANIMAL BEHAVIOR; ANXIETY; AUTISM; C57BL MOUSE; DRUG EFFECTS; EPILEPSY; EPILEPTIC STATE; HAPLOINSUFFICIENCY; MALE; MAZE TEST; MEMORY; METABOLISM; MOUSE; MUTATION; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; SEIZURE; SOCIAL BEHAVIOR;

ANIMALS; ANXIETY; AUTISM SPECTRUM DISORDER; BEHAVIOR, ANIMAL; EPILEPSY; HAPLOINSUFFICIENCY; KAINIC ACID; MALE; MAZE LEARNING; MEMORY; MICE; MICE, INBRED C57BL; MUTATION; NEURONS; PTEN PHOSPHOHYDROLASE; SEIZURES; SOCIAL BEHAVIOR; STATUS EPILEPTICUS;

EID: 84994430665     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep36559     Document Type: Article

References (51)

1. El Achkar, C. M. & Spence, S. J. Clinical characteristics of children and young adults with co-occurring autism spectrum disorder and epilepsy. Epilepsy Behav 47, 183-190 (2015).
2. Levisohn, P. M. The autism-epilepsy connection. Epilepsia 48 Suppl 9, 33-35 (2007).
3. Tuchman, R. & Rapin, I. Epilepsy in autism. Lancet Neurol 1, 352-358 (2002).
4. Kohane, I. S. et al. The co-morbidity burden of children and young adults with autism spectrum disorders. PLoS One 7, e33224 (2012).
5. Cohen, I. L. et al. Why are autism and the fragile-X syndrome associated? Conceptual and methodological issues. Am J Hum Genet 48, 195-202 (1991).
6. Smalley, S. L. Autism and tuberous sclerosis. J Autism Dev Disord 28, 407-414 (1998).
7. Endersby, R. & Baker, S. J. PTEN signaling in brain: neuropathology and tumorigenesis. Oncogene 27, 5416-5430 (2008).
8. Kwon, C. H. et al. Pten regulates neuronal arborization and social interaction in mice. Neuron 50, 377-388 (2006).
9. Lugo, J. N., Smith, G. D., Morrison, J. B. & White, J. Deletion of PTEN produces deficits in conditioned fear and increases fragile X mental retardation protein. Learn Mem 20, 670-673 (2013).
10. Backman, S. A. et al. Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease. Nat Genet 29, 396-403 (2001).
11. Ljungberg, M. C., Sunnen, C. N., Lugo, J. N., Anderson, A. E. & D'Arcangelo, G. Rapamycin suppresses seizures and neuronal hypertrophy in a mouse model of cortical dysplasia. Dis Model Mech 2, 389-398 (2009).
12. Lugo, J. N. et al. Deletion of PTEN produces autism-like behavioral deficits and alterations in synaptic proteins. Front Mol Neurosci 7, 27 (2014).
13. Clipperton-Allen, A. E. & Page, D. T. Decreased aggression and increased repetitive behavior in Pten haploinsufficient mice. Genes Brain Behav 14, 145-157 (2015).
14. Lugo, J. N., Swann, J. W. & Anderson, A. E. Early-life seizures result in deficits in social behavior and learning. Exp Neurol (2014).
15. Bernard, P. B. et al. Phosphorylation of FMRP and alterations of FMRP complex underlie enhanced mLTD in adult rats triggered by early life seizures. Neurobiol Dis (2013).
16. Morris, R. G., Garrud, P., Rawlins, J. N. & O'Keefe, J. Place navigation impaired in rats with hippocampal lesions. Nature 297, 681-683 (1982).
17. Wiltgen, B. J., Sanders, M. J., Ferguson, C., Homanics, G. E. & Fanselow, M. S. Trace fear conditioning is enhanced in mice lacking the delta subunit of the GABAA receptor. Learn Mem 12, 327-333 (2005).
18. Hoeffer, C. A. et al. Removal of FKBP12 enhances mTOR-Raptor interactions, LTP, memory, and perseverative/repetitive behavior. Neuron 60, 832-845 (2008).
19. Bhattacharya, A. et al. Genetic removal of p70 S6 kinase 1 corrects molecular, synaptic, and behavioral phenotypes in fragile X syndrome mice. Neuron 76, 325-337 (2012).
20. Sharma, A. et al. Dysregulation of mTOR signaling in fragile X syndrome. J Neurosci 30, 694-702 (2010).
21. Meikle, L. et al. A mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival. J Neurosci 27, 5546-5558 (2007).
22. de Vries, P. J. Targeted treatments for cognitive and neurodevelopmental disorders in tuberous sclerosis complex. Neurotherapeutics 7, 275-282 (2010).
23. Kelleher, R. J. 3rd & Bear, M. F. The autistic neuron: troubled translation? Cell 135, 401-406 (2008).
24. Varga, E. A., Pastore, M., Prior, T., Herman, G. E. & McBride, K. L. The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly. Genet Med 11, 111-117 (2009).
25. Williams, A. E., Giust, J. M., Kronenberger, W. G. & Dunn, D. W. Epilepsy and attention-deficit hyperactivity disorder: links, risks, and challenges. Neuropsychiatric disease and treatment 12, 287-296 (2016).
26. Pineda, E. et al. Behavioral impairments in rats with chronic epilepsy suggest comorbidity between epilepsy and attention deficit/ hyperactivity disorder. Epilepsy & Behavior 31, 267-275 (2014).
27. Langford-Smith, A. et al. Hyperactive behaviour in the mouse model of mucopolysaccharidosis IIIB in the open field and home cage environments. Genes Brain Behav 10, 673-682 (2011).
28. Bernard, P. B., Castano, A. M., Beitzel, C. S., Carlson, V. B. & Benke, T. A. Behavioral changes following a single episode of early-life seizures support the latent development of an autistic phenotype. Epilepsy Behav 44, 78-85 (2015).
29. Nadler, J. J. et al. Automated apparatus for quantitation of social approach behaviors in mice. Genes Brain Behav 3, 303-314 (2004).
30. Page, D. T., Kuti, O. J., Prestia, C. & Sur, M. Haploinsufficiency for Pten and Serotonin transporter cooperatively influences brain size and social behavior. Proc Natl Acad Sci USA 106, 1989-1994 (2009).
31. Clipperton-Allen, A. E. & Page, D. T. Pten haploinsufficient mice show broad brain overgrowth but selective impairments in autismrelevant behavioral tests. Human Molecular Genetics 23, 3490-3505 (2014).
32. Kwon, C. H. et al. Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease. Nat Genet 29, 404-411 (2001).
33. Napoli, E. et al. Mitochondrial dysfunction in Pten haplo-insufficient mice with social deficits and repetitive behavior: interplay between Pten and p53. PLoS One 7, e42504 (2012).
34. Sejourne, J., Llaneza, D., Kuti, O. J. & Page, D. T. Social Behavioral Deficits Coincide with the Onset of Seizure Susceptibility in Mice Lacking Serotonin Receptor 2c. PLoS One 10, e0136494 (2015).
35. Chang, Y. C., Guo, N. W., Huang, C. C., Wang, S. T. & Tsai, J. J. Neurocognitive attention and behavior outcome of school-age children with a history of febrile convulsions: a population study. Epilepsia 41, 412-420 (2000).
36. Chang, Y. C., Guo, N. W., Wang, S. T., Huang, C. C. & Tsai, J. J. Working memory of school-aged children with a history of febrile convulsions: a population study. Neurology 57, 37-42 (2001).
37. Tao, K., Ichikawa, J., Matsuki, N., Ikegaya, Y. & Koyama, R. Experimental febrile seizures induce age-dependent structural plasticity and improve memory in mice. Neuroscience 318, 34-44 (2016).
38. Raijmakers, M. et al. Experimental febrile seizures increase dendritic complexity of newborn dentate granule cells. Epilepsia (2016).
39. Stiedl, O. & Spiess, J. Effect of tone-dependent fear conditioning on heart rate and behavior of C57BL/6N mice. Behav Neurosci 111, 703-711 (1997).
40. Zhang, B. & Wong, M. Pentylenetetrazole-induced seizures cause acute, but not chronic, mTOR pathway activation in rat. Epilepsia 53, 506-511 (2012).
41. Zeng, L. H., Rensing, N. R. & Wong, M. The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy. J Neurosci 29, 6964-6972 (2009).
42. Shima, A. et al. Activation of mTOR signaling pathway is secondary to neuronal excitability in a mouse model of mesio-temporal lobe epilepsy. European Journal of Neuroscience 41, 974-986 (2015).
43. Koh, S., Storey, T. W., Santos, T. C., Mian, A. Y. & Cole, A. J. Early-life seizures in rats increase susceptibility to seizure-induced brain injury in adulthood. Neurology 53, 915-921 (1999).
44. Hoffmann, A. F., Zhao, Q. & Holmes, G. L. Cognitive impairment following status epilepticus and recurrent seizures during early development: support for the "two-hit hypothesis". Epilepsy Behav 5, 873-877 (2004).
45. Chan, J., Jones, N. C., Bush, A. I., O'Brien, T. J. & Kwan, P. A mouse model of Alzheimer's disease displays increased susceptibility to kindling and seizure-associated death. Epilepsia 56, e73-e77 (2015).
46. Sunnen, C. N. et al. Inhibition of the mammalian target of rapamycin blocks epilepsy progression in NS-Pten conditional knockout mice. Epilepsia 52, 2065-2075 (2011).
47. Nguyen, L. H. et al. mTOR inhibition suppresses established epilepsy in a mouse model of cortical dysplasia. Epilepsia 56, 636-646 (2015).
48. Barnwell, L. F. et al. Kv4.2 knockout mice demonstrate increased susceptibility to convulsant stimulation. Epilepsia 50, 1741-1751 (2009).
49. Lugo, J. N., Smith, G. D. & Holley, A. J. Trace fear conditioning in mice. J Vis Exp (2014).
50. Lugo, J. N., Brewster, A. L., Spencer, C. M. & Anderson, A. E. Kv4.2 knockout mice have hippocampal-dependent learning and memory deficits. Learn Mem 19, 182-189 (2012).
51. Lugo, J. N. et al. Altered phosphorylation and localization of the A-type channel, Kv4.2 in status epilepticus. J Neurochem 106, 1929-1940 (2008).